Document Mentions (3 shared documents)

EFTA02686169

2 mentions1 same-page

Page ?Same page

del Capital S.A.E. Egypt Christopher J. Elias President and Chief Executive Officer PATH (Programme for USA Appropriate Technology in Health) Johan Eliasch Chairman and Chief Executive Officer Head NV United Kingdom Olafur Eliasson Artist Studio Olafur Eliasson Denmark Gerri Elliott Executive Vi

ssion, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Damen Chairman Damen Shipyards Group Netherlands Brian A. Dames Chief Executive Officer Eskom Holdings Limited South Africa Dang

EFTA02686246

2 mentions1 same-page

Page ?Same page

EFTA02707384

2 mentions1 same-page

Page ?Same page

s John Ehara Felix Ehrat Barry Eichengreen Ralph Eichler Espen Barth Eide Jarg Eigendorf Stuart E. Eizenstat Daniel Ek Christopher J. Elias Johan Eliasch Olafur Eliasson Jennifer Elisseeff Mohamed Elkeiy Robert Elliott Michael J. Elliott Lawrence Elliott David T. Ellwood Bert van der Els Amir

Bloomberg News USA MasterCard International USA Incorporated Citadel Capital SAE Purpose Siemens AG Research in Motion Limited LANXESS AG Morphlabs Inc. Aftenposten Harvard Business Review Rensselaer Polytechnic Institute (RPI) Royal Philips Electronics Egypt USA Germany Canada Germany USA

Mutual Connections (2,020)

Entities connected to both Johan Eliasch and Morphlabs Inc.

Raghida Dergham